Summary
Autoantibodies to the 64,000-Mr (64K) islet cell protein, identified as glutamic acid decarboxylase, were assayed in 46 Type 1 (insulin-dependent) diabetic patients with a disease duration of more than 5 years. Of 46 Type 1 diabetic patients, 18 (39.1 %) were found to be positive for 64K antibodies and 12 of these patients had been diagnosed with autoimmune thyroid disease. Serum C-peptide levels were not detectable in 15 of 18 patients positive for 64K antibodies. The samples were also tested for titres of islet cell antibodies. Islet cell antibodies were detected in 15 (32.6%) of the 46 patients and all the islet cell antibody positive patients were also found to be positive for 64K antibodies. Furthermore, of these 15 patients 12 had previously been diagnosed with autoimmune thyroid disease. A correlation between levels of 64K antibodies and islet cell antibody titre revealed that higher levels of 64K antibodies were observed in patients who had higher islet cell antibody titre. These results demonstrate that most long-term Type 1 diabetic patients with 64K antibodies were also positive for islet cell antibodies complicated by autoimmune thyroid disease.
Article PDF
Similar content being viewed by others
References
Bottazzo GF, Florin-Christensen, A. Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet II: 1279–1282
Lernmark Å., Freedman ZR, Hofmann C et al. (1978) Islet-cell surface antibodies in juvenile diabetes mellitus. N Engl J Med 299: 375–380
Lendrum R, Walker G, Cudworth AG et al. (1976) Islet-cell antibodies in diabetes mellitus. Lancet I: 1273–1276
MacCuish AC, Jordan J, Cambell CJ, Duncan LJP, Irvine WJ (1974) Antibodies to pancreatic-islet cells in insulin dependent diabetics with coexistent autoimmune disease. Lancet II: 1529–1533
Irvine WJ, McCallum CJ, Gray RS et al. (1977) Pancreatic islet cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes 26: 138–147
Yamaguchi Y, Chikuba N, Ueda Y et al. (1991) Islet cell antibodies in patients with autoimmune thyroid disease. Diabetes 40: 319–322
Baekkeskoy S, Neisen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298: 167–169
Baekkeskov S, Landin M, Kristensen JK et al. (1987) Antibodies to a 64,000-Mr human islet cell protein precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79: 926–934
Christie M, Landin-Olsson M, Sundkvist G, Dahlquist G, Lernmark Å, Baekkeskov S (1988) Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed Type 1 (insulin-dependent) diabetes. Diabetologia 31: 597–602
Christie MR, Daneman D, Champagne P, Delovitch TL (1990) Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of Type 1 diabetes. Diabetes 39: 653–656
Atkinson MA, Maclaren NK, Sharp DW, Lacy PE, Riley WJ (1990) 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 335: 1357–1360
Baekkeskov S, Aanstoot HJ, Christgau S et al. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151–156
Takahashi A, Tsujihata M, Yokota A et al. (1986) A new method of detection of islet cell antibodies (ICA) using peroxidase labelled protein A and incidence of ICA in Type 1 (insulin-dependent) diabetes. Diabetologia 29: 378–382
Yamaguchi Y, Chikuba N, Nakanishi T et al. (1991) Production of islet cell antibodies from Epstein-Barr virus-transformed peripheral blood lymphocytes in Type 1 (insulin-dependent) diabetic patients. Diabetologia 34: 511–514
Fialkow PJ, Zavala C, Nielsen R (1975) Thyroid autoimmunity: increased frequency in relatives of insulin-dependent diabetes patients. Ann Intern Med 83: 170–176
Riley WJ, Maclaren NK, Lezotte DC, Spillar RP, Rosenbloom AL (1981) Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case of routine screening. J Pediatr 99: 350–354
Betterle C, Zanette F, Pedini B et al. (1984) Clinical and subclinical organ-specific autoimmune manifestations in Type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 26: 431–436
Landin-Olsson M, Karlsson A, Dahlquist G et al. (1989) Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32: 387–395
Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL (1990) Distinct antibody specificities to a 64-kD islet cell antigen in Type 1 diabetes as revealed by trypsin treatment. J Exp Med 172: 789–794
Lo SSS, Christie MR, Tun RYM et al. (1991) Antibodies to glutamic acid decarboxylase and tryptic fragments of 64-kD islet antigen as predictors of diabetes. Diabetologia 34 [Suppl 2]: A18 (Abstract)
Gianani R, Rabizadeh A, Jackson R, Schiffrin A, Eisenbarth GS (1991) Heterogeneity of cytoplasmic islet cell autoantibodies. Diabetes 40 [Suppl 1]: 224A (Abstract)
Gianani R, Jackson R, Eisenbarth GS (1991) Evidence that the autoantigen of restricted ICA is GAD. Diabetes Res Clin Pract 14 [Suppl 1]: S13 (Abstract)
Nouvo SA, Baker JR, Wartofsky L, Lukes YG, Burman KD (1988) Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease. Diabetes 37: 317–320
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kawasaki, E., Moriuchi, R., Takino, H. et al. Autoantibodies to 64,000-Mr islet cell protein in long-term Type 1 (insulin-dependent) diabetic patients. Diabetologia 35, 748–752 (1992). https://doi.org/10.1007/BF00429095
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00429095